Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
New York, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) today announced that it has launched a new product offering for healthcare providers along with the signing of two new mid-Atlantic
SCWorx Corp (NASDAQ:WORX) today announced the renewal and expansion of a data service agreement with an existing 500+ bed hospital in New England.
The healthcare provider was previously under a 1